BusinessEuropean Medicines Agency Grants Accelerated Assessment of Marketing Authorization Application for Xilonix™, XBiotech’s True Human™ Therapeutic Antibody Treatment for Advanced Colorectal CancerBy Nasdaq OMXApr 4, 2016, 7:00 AM UTC
BusinessVersartis Presents Confirmatory 18-Month Adherence Data from Ongoing Somavaratan Extension Study at Late-Breaker Session at ENDO Annual MeetingBy Nasdaq OMXApr 1, 2016, 11:00 AM UTC
BusinessAkari Therapeutics Announces Positive Preliminary Results from First PNH Patient Treated With CoversinBy Nasdaq OMXMar 31, 2016, 8:03 PM UTC
BusinessKaryopharm Receives NIAID Grant to Advance Development of KPT-350 for the Treatment of LupusBy Nasdaq OMXMar 31, 2016, 12:30 PM UTC
BusinessCorium to Present at 15th Annual Needham Healthcare ConferenceBy Nasdaq OMXMar 31, 2016, 12:00 PM UTC
BusinessOrigent Data Sciences and Cytokinetics Announce Research Collaboration on Predictive Analytics Model in ALSBy Nasdaq OMXMar 31, 2016, 11:30 AM UTC
BusinessArno Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business UpdateBy Nasdaq OMXMar 30, 2016, 8:17 PM UTC
